IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors.

Beyranvand Nejad E, Labrie C, van Elsas MJ, Kleinovink JW, Mittrücker HW, Franken KLMC, Heink S, Korn T, Arens R, van Hall T, van der Burg SH

Open source

DOI: 10.1136/jitc-2021-002460
Published: 2021 Apr
Container: Journal for immunotherapy of cancer
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2021-002460,
  title = {IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors.},
  author = {Beyranvand Nejad E and Labrie C and van Elsas MJ and Kleinovink JW and Mittrücker HW and Franken KLMC and Heink S and Korn T and Arens R and van Hall T and van der Burg SH},
  year = {2021},
  journal = {Journal for immunotherapy of cancer},
  doi = {10.1136/jitc-2021-002460},
  url = {https://doi.org/10.1136/jitc-2021-002460}
}

RIS

TY  - JOUR
TI  - IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors.
AU  - Beyranvand Nejad E
AU  - Labrie C
AU  - van Elsas MJ
AU  - Kleinovink JW
AU  - Mittrücker HW
AU  - Franken KLMC
AU  - Heink S
AU  - Korn T
AU  - Arens R
AU  - van Hall T
AU  - van der Burg SH
PY  - 2021
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2021-002460
UR  - https://doi.org/10.1136/jitc-2021-002460
ER  -

APA

E, B. N., C, L., MJ, V. E., JW, K., HW, M., KLMC, F., S, H., T, K., R, A., T, V. H., & SH, V. D. B. (2021). IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2021-002460

Source records

pubmed · retrieved 2026-09-26T20:48:13.794Z
europe-pmc · retrieved 2026-09-26T20:48:13.813Z
doaj · retrieved 2026-09-26T20:48:13.795Z